Curis and Aurigene Extend Exclusivity Period of Immuno-Oncology and Precision Oncology Collaboration
Jan 09, 2017 12:00 pm UTC| Business
LEXINGTON, Mass., Jan. 09, 2017 -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of cancer, today...
Southcross Energy Announces Leadership Change
Jan 09, 2017 12:00 pm UTC| Business
DALLAS, Texas, Jan. 09, 2017 -- Southcross Energy Partners, L.P. (NYSE:SXE) (“Southcross”) and Southcross Holdings LP (“Holdings”) announced today a consolidation of the roles of Chairman and Chief Executive Officer of...
Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
Jan 09, 2017 12:00 pm UTC| Business
Austin, Texas, Jan. 09, 2017 -- Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on the development and commercialization of novel formulations of injectable drugs, announced that Mr. Paul R....
Jan 09, 2017 12:00 pm UTC| Business
SANTA MONICA, Calif., Jan. 09, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders,...
Jan 09, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., Jan. 09, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced preliminary unaudited 2016 financial results and guidance for 2017. Daniel J. Abdun-Nabi, president and chief executive officer...
The Joint Corp. Sells Chicago Area Regional Developer Rights to Existing Franchisees
Jan 09, 2017 12:00 pm UTC| Business
Transfers 6 Chicago Area Clinics to Existing Franchisees; Consolidates 5 Clinics in Chicago and 3 in Upstate N.Y. Announces $5 Million Line of Credit SCOTTSDALE, Ariz., Jan. 09, 2017 -- The Joint Corp....
Jan 09, 2017 12:00 pm UTC| Business
SAINT-GENIS-POUILLY, France, Jan. 09, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear Medicine (MNM), today issued a statement from...